Tag: Food and Drug Administration

FDA approves Janssen’s TECVAYLI for multiple myeloma treatment

businessnewstoday- October 27, 2022

The Janssen Pharmaceutical Companies, a subsidiary of Johnson & Johnson, announced the US Food and Drug Administration's approval of its first bispecific T-cell engager antibody, ... Read More

Ayala Pharmaceuticals AL102 gets FDA fast track status in desmoid tumors

businessnewstoday- September 29, 2022

Ayala Pharmaceuticals has been granted fast track designation for its oral gamma-secretase inhibitor AL102 by the US Food and Drug Administration (FDA) for the treatment ... Read More

Lupin Limited launches Generic Suprep Bowel Prep Kit in the US

pallavi123- September 20, 2022

Indian pharma company Lupin Limited has launched Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Solution, 17.5 g/3.13 g/1.6 g per 6 ounces, after getting ... Read More

US FDA approves Opdivo, Cabometyx combo for advanced renal cell carcinoma

pharmanewsdaily- January 26, 2021

The US Food and Drug Administration (FDA) has approved the combination of Bristol Myers Squibb’ Opdivo (nivolumab) and Exelixis’ Cabometyx (cabozantinib) as a first line ... Read More

AstraZeneca gets BRILINTA FDA approval for reducing risk of stroke in acute ischemic stroke or high-risk transient ischemic attack

pharmanewsdaily- November 8, 2020

BRILINTA FDA approval : AstraZeneca has bagged approval for BRILINTA (ticagrelor) from the US  Food and Drug Administration for its use in reducing the risk ... Read More

Masimo gets FDA clearance for Centroid patient monitoring sensor

pharmanewsdaily- June 28, 2020

Masimo, a US medical device company, has received clearance from the US Food and Drug Administration (FDA) for Centroid, the company's wearable, wireless patient orientation, ... Read More

PADCEV, KEYTRUDA combination for advanced bladder cancer gets FDA breakthrough therapy status

pharmanewsdaily- February 20, 2020

PADCEV, KEYTRUDA combination : Astellas Pharma and Seattle Genetics said that the combination of PADCEV (enfortumab vedotin-ejfv) and Merck's anti-PD-1 therapy KEYTRUDA (pembrolizumab) has been ... Read More

LIAISON QFT-Plus automated screening solution gets FDA nod for TB detection

pharmanewsdaily- January 1, 2020

Qiagen and DiaSorin have secured approval from the US Food and Drug Administration (FDA) to use QuantiFERON-TB Plus (QFT-Plus automated screening solution) on the latter’s ... Read More

Stryker hip lawyers on Recall of Stryker hip implants

pharmanewsdaily- August 5, 2013

What are Stryker Hip Implants? What is Stryker Hip Recall? The Stryker Orthoaedics company announced voluntary recall of the rejuvenate and ABG II modular neck ... Read More